Medtronic plc stock gains on strong quarterly figures and guidance
Published on 09/06/2026 at 10:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Medtronic plc (ISIN IE00BTN1Y115) stock is trading in the mid-90 dollar range as of September 5, 2026, after the medical technology group reported quarterly earnings per share of 1.45 dollars on revenue of 9.76 billion dollars, with revenue up 13.7 percent year over year according to recent market data.
Latest earnings beat and outlook
According to recent analysis compiled by MarketBeat, Medtronic last released its quarterly earnings data on September 1, 2026, reporting earnings per share of 1.45 dollars and revenue of 9.76 billion dollars for the period.
The same MarketBeat overview notes that this EPS figure was 0.06 dollars above the consensus estimate of 1.39 dollars, while revenue exceeded expectations of 9.55 billion dollars and rose 13.7 percent compared with the same quarter a year earlier, when EPS stood at 1.26 dollars.
Medtronic’s return on equity for the latest reported quarter was 14.89 percent, and its net margin was 13.93 percent, indicating a profitable profile that can be relevant for long term investors assessing the company’s ability to convert revenue growth into earnings.
Guidance and consensus view
The same MarketBeat data set highlights that Medtronic has issued guidance for the coming periods, setting its second quarter of fiscal 2027 earnings guidance in a range of 1.32 to 1.34 dollars per share and its full fiscal year 2027 earnings guidance between 5.94 and 6.00 dollars per share.
Research analysts following the stock expect that Medtronic will post about 5.96 dollars in earnings per share for the current fiscal year, placing the guidance range broadly in line with consensus and offering investors a relatively tight corridor for earnings expectations.
According to consensus data summarized by MarketBeat, analysts currently assign Medtronic a rating in the range of a Moderate Buy, with an average price target of 103.92 dollars for the shares.
For investors, the combination of an earnings beat, double digit revenue growth, and guidance consistent with consensus provides a framework for assessing whether the current share price in the mid-90 dollar range leaves upside toward that average target.
More Medtronic plc stock and fundamentals
Investors who want to follow Medtronic plc stock more closely can explore additional price data, filings and background on the company’s medical technology portfolio.
Dividend profile and income perspective
Medtronic also underpins its equity story with a regular dividend. MarketBeat’s Medtronic coverage states that the company recently announced a quarterly dividend of 0.72 dollars per share, corresponding to an annualized dividend of 2.88 dollars.
Based on a share price around 94.12 dollars as reported in recent trading data, this payout translates into a dividend yield of about 3.1 percent, which can be attractive for income oriented investors in the healthcare technology sector.
For shareholders of record as of September 25, 2026, the dividend is scheduled to be paid on October 16, 2026, with the ex dividend date also falling on September 25, 2026, creating a clear timetable for the next cash distribution.
Recent stock performance and valuation context
According to the price performance snapshot embedded in the MarketBeat analysis, Medtronic shares opened around 94.12 dollars on the latest trading day referenced in the data set, with the stock up about 1.1 percent in that session.
The same overview notes that Medtronic’s 50 day moving average stands at about 86.78 dollars, while its 200 day moving average is approximately 85.37 dollars, indicating that the current price is trading above both medium term and longer term trend lines.
For investors, a share price above these moving averages can be interpreted as a positive technical signal, although the fundamental picture provided by the recent earnings beat and guidance often carries more weight in long term decisions than short term chart levels.
Medtronic medical devices as a revenue driver
Medtronic plc is widely known for its broad portfolio of medical devices, including implantable cardiac pacemakers and defibrillators, insulin pumps, and other technologies that support chronic disease management and surgical procedures.
In recent years, the company has invested heavily in minimally invasive and robotic assisted solutions, as well as in data driven care platforms that integrate devices with software and services to help physicians and patients monitor outcomes more closely.
While the latest quarter’s 9.76 billion dollars in revenue reflects contributions across multiple segments, the continued demand for cardiovascular and diabetes therapies remains an important pillar for the group’s growth story and helps explain the double digit revenue increase compared with the prior year quarter.
Stock and investor perspective
Medtronic plc stock most recently traded around 94.12 dollars on the New York Stock Exchange as of September 5, 2026, with the latest session showing a gain of about 1.15 percent in some real time news feeds.
With the shares trading below the consensus price target of 103.92 dollars yet above key moving averages, the market is balancing Medtronic’s solid earnings and dividend profile against broader healthcare sector considerations and macroeconomic factors.
Medtronic plc stock key data
- Company: Medtronic plc
- ISIN: IE00BTN1Y115
- Ticker: MDT
- Trading venue: NYSE
- Price (as of September 5, 2026): 94.12 USD
- Market capitalization: [value] USD (as of September 5, 2026)
- Sector / Industry: Health Care / Medical Devices
- Index membership: S&P 500
